Antidepressant Sertraline Hydrochloride Inhibits the Growth of HER2+ AU565 Breast Cancer Cell Line through Induction of Apoptosis and Cell Cycle Arrest

  • Authors: Fayyaz S.1, Atia-Tul-Wahab 2, Irshad R.3, Siddiqui R.4, Choudhary M.2
  • Affiliations:
    1. National Institute of Virology, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi
    2. Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi
    3. H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi
    4. Food Chemistry and Nutrition Science Laboratory, College of Agriculture, Virginia State University
  • Issue: Vol 24, No 14 (2024)
  • Pages: 1038-1046
  • Section: Oncology
  • URL: https://snv63.ru/1871-5206/article/view/643832
  • DOI: https://doi.org/10.2174/0118715206304918240509111700
  • ID: 643832

Cite item

Full Text

Abstract

Background:Drug repurposing in oncology promises benefits to many patients through its ability to provide novel, and fast-tracked treatments. Previous studies have demonstrated that depression may influence tumor progression. Anti-proliferative activity of certain antidepressants, mainly selective serotonin reuptake inhibitors (SSRIs), are reported in the literature.

Objective:This study was conducted to repurpose selective serotonin reuptake inhibitors (SSRIs) for the treatment of breast cancers, and it merits further validation and research.

Experimental:Changes in cell morphology were studied using DAPI staining, while the Annexin V/PI method was employed for apoptotic analysis. The expression of specific genes involved in cancer progression was also analyzed via RT-PCR. Caspase-3 activation was measured through fluorometric assay.

Results:We have identified that sertraline hydrochloride significantly inhibited the growth of breast cancer cell in vitro. Preliminary mechanistic studies demonstrated that the cytotoxicity of sertraline hydrochloride was possibly through the induction of apoptosis, as inferred from enhanced nuclear fragmentation, flow cytometric data, and caspase-3/7 activation. Gene expression analysis also showed an increased expression of pro-apoptotic Bax, and a slight decrease in oncogene c-myc in the presence of sertraline hydrochloride.

Conclusion:In conclusion, our study suggest that sertraline hydrochloride, an antidepressant drug, can potentially be used for the treatment of breast cancer.

About the authors

Sharmeen Fayyaz

National Institute of Virology, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi

Email: info@benthamscience.net

Atia-Tul-Wahab

Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi

Author for correspondence.
Email: info@benthamscience.net

Rimsha Irshad

H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi

Email: info@benthamscience.net

Rafat Siddiqui

Food Chemistry and Nutrition Science Laboratory, College of Agriculture, Virginia State University

Email: info@benthamscience.net

M. Choudhary

Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi

Author for correspondence.
Email: info@benthamscience.net

References

  1. Chang, L.; Weiner, L.S.; Hartman, S.J.; Horvath, S.; Jeste, D.; Mischel, P.S.; Kado, D.M. Breast cancer treatment and its effects on aging. J. Geriatr. Oncol., 2019, 10(2), 346-355. doi: 10.1016/j.jgo.2018.07.010 PMID: 30078714
  2. Tate, C.R.; Rhodes, L.V.; Segar, H.C.; Driver, J.L.; Pounder, F.N.; Burow, M.E.; Collins-Burow, B.M. Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat. Breast Cancer Res., 2012, 14(3), R79. doi: 10.1186/bcr3192 PMID: 22613095
  3. Soomro, R.; Faridi, S.; Khurshaidi, N.; Zahid, N.; Mamshad, I. Age and stage of breast cancer in Pakistan: An experience at a tertiary care center. J. Pak. Med. Assoc., 2018, 68(11), 1682-1685. PMID: 30410149
  4. Zahid, I.; Ahmed, A.; Ladiwala, Z.F.; Sheikh, R.; Memon, A. Breast self-examination awareness and practices in young women in developing countries: A survey of female students in Karachi, Pakistan. J. Educ. Health Promot., 2018, 7(1), 90. doi: 10.4103/jehp.jehp_147_17 PMID: 30079361
  5. Badran, A. Atia-tul-Wahab; Fayyaz, S.; Baydoun, E.; Choudhary, M.I. Small molecular leads differentially active against HER2 positive and triple negative breast cancer cell lines. Med. Chem., 2019, 15(7), 738-742. doi: 10.2174/1573406414666181106143912 PMID: 30398120
  6. Das, J.R.; Fryar-Tita, E.B.; Zhou, Y.; Green, S.; Southerland, W.M.; Bowen, D. Sequence-dependent administration of 5-fluorouracil maintains methotrexate antineoplastic activity in human estrogen-negative breast cancer and protects against methotrexate cytotoxicity in human bone marrow. Anticancer Res., 2007, 27(6B), 3791-3799. PMID: 18225534
  7. Gombos, A.; Franzoi, M.A.; Awada, A. Investigational drugs in early stage clinical trials for the treatment of HER2+ breast cancer. Exp. Opin. Inv. Drug., 2019, 28(7), 617-627.
  8. Grassi, L.; Nanni, M.G.; Rodin, G.; Li, M.; Caruso, R. The use of antidepressants in oncology: A review and practical tips for oncologists. Ann. Oncol., 2018, 29(1), 101-111. doi: 10.1093/annonc/mdx526 PMID: 29272358
  9. Han, H.; Guo, W.; Shi, W.; Yu, Y.; Zhang, Y.; Ye, X.; He, J. Hypertension and breast cancer risk: A systematic review and meta-analysis. Sci. Rep., 2017, 7(1), 44877. doi: 10.1038/srep44877 PMID: 28317900
  10. Lieb, J. Defeating cancer with antidepressants. Ecancermedicalscience, 2008, 2, 88. PMID: 22275973
  11. Hinz, A.; Krauss, O.; Hauss, J.P.; Höckel, M.; Kortmann, R.D.; Stolzenburg, J.U.; Schwarz, R. Anxiety and depression in cancer patients compared with the general population. Eur. J. Cancer Care (Engl.), 2010, 19(4), 522-529. doi: 10.1111/j.1365-2354.2009.01088.x PMID: 20030697
  12. Balentine, C.J.; Hermosillo-Rodriguez, J.; Robinson, C.N.; Berger, D.H.; Naik, A.D. Depression is associated with prolonged and complicated recovery following colorectal surgery. J. Gastrointest. Surg., 2011, 15(10), 1712.
  13. Narayanan, V. Ocular Adverse effects of antidepressants–need for an ophthalmic screening and follow up protocol. O.Res. An. Int. J., 2019, 20, 1-6. doi: 10.9734/or/2019/v10i330107
  14. Haskell, S.E.; Hermann, G.M.; Reinking, B.E.; Volk, K.A.; Peotta, V.A.; Zhu, V.; Roghair, R.D. Sertraline exposure leads to small left heart syndrome in adult mice. Pediatr. Res., 2013, 73(3), 286-293. doi: 10.1038/pr.2012.183 PMID: 23232669
  15. Kotapati, V.P.; Khan, A.M.; Dar, S.; Begum, G.; Bachu, R.; Adnan, M.; Zubair, A.; Ahmed, R.A. The effectiveness of selective serotonin reuptake inhibitors for treatment of obsessive-compulsive disorder in adolescents and children: A systematic review and meta-analysis. Front. Psychiatry, 2019, 10, 523. doi: 10.3389/fpsyt.2019.00523 PMID: 31447707
  16. Patel, R. Anti-proliferative effects of selected antidepressant agents on human metastatic breast cancer cell line, MDA-MB-231., Doctoral dissertation, Long Island University, The Brooklyn Center., 2013.
  17. Zong, D.; Zielinska-Chomej, K.; Juntti, T.; Mörk, B.; Lewensohn, R.; Hååg, P.; Viktorsson, K. Harnessing the lysosome-dependent antitumor activity of phenothiazines in human small cell lung cancer. Cell Death Dis., 2014, 5(3), e1111. doi: 10.1038/cddis.2014.56 PMID: 24625970
  18. Goyette, M.A.; Cusseddu, R.; Elkholi, I.; Abu-Thuraia, A.; El-Hachem, N.; Haibe-Kains, B.; Gratton, J.P.; Côté, J.F. AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple-negative breast cancer. Oncotarget, 2019, 10(21), 2055-2067. doi: 10.18632/oncotarget.26725 PMID: 31007848
  19. Rosetti, M.; Frasnelli, M.; Tesei, A.; Zoli, W.; Conti, M. Cytotoxicity of different selective serotonin reuptake inhibitors (SSRIs) against cancer cells. J. Exp. Ther. Oncol., 2006, 6(1), 23-29. PMID: 17228521
  20. Abdel Karim, N.F.; Hassan, R.; Siddiqi, N.I.; Eldessouki, I.; Gaber, O.; Rahouma, M.; Kamel, M.; Yellu, M.; Gulati, S.; Xie, C.; Magdy, M.; Pruemer, J. Impact of tricyclic antidepressants, selective serotonin reuptake inhibitors, and other antidepressants on overall survival of patients with advanced lung cancer from 2004 to 2014: University of Cincinnati experience. J. Int. Med. Res., 2019, 47(12), 6016-6026. doi: 10.1177/0300060519862469 PMID: 31640444
  21. Serafeim, A.; Holder, M.J.; Grafton, G.; Chamba, A.; Drayson, M.T.; Luong, Q.T.; Bunce, C.M.; Gregory, C.D.; Barnes, N.M.; Gordon, J. Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells. Blood, 2003, 101(8), 3212-3219. doi: 10.1182/blood-2002-07-2044 PMID: 12515726
  22. Gwynne, W.D.; Shakeel, M.S.; Girgis-Gabardo, A.; Hassell, J.A. The role of serotonin in breast cancer stem cells. Molecules, 2021, 26(11), 3171. doi: 10.3390/molecules26113171 PMID: 34073226
  23. Duarte, D.; Vale, N. Antidepressant drug sertraline against human cancer cells. Biomolecules, 2022, 12(10), 1513. doi: 10.3390/biom12101513 PMID: 36291722
  24. Taler, M.; Gil-Ad, I.; Brener, I.; Hornfeld, S.H.; Weizman, A. Complex effects of sertraline and citalopram on in vitro murine breast cancer proliferation and on in vivo progression and anxiety level. Int. J. Mol. Sci., 2022, 23(5), 2711. doi: 10.3390/ijms23052711 PMID: 35269853
  25. Bar-Shalom, R.; Bergman, M.; Grossman, S.; Azzam, N.; Sharvit, L.; Fares, F. Inula viscosa extract inhibits growth of colorectal cancer cells in vitro and in vivo through induction of apoptosis. Front. Oncol., 2019, 9, 227. doi: 10.3389/fonc.2019.00227 PMID: 31024836
  26. Sturzu, A.; Sheikh, S.; Echner, H.; Deeg, M.; Nägele, T.; Weidenmaier, C.; Schwentner, C.; Horger, M.; Ernemann, U.; Heckl, S. Chemosensitization of prostate carcinoma cells with a receptor-directed Smac conjugate. Med. Chem., 2016, 12(5), 412-418. doi: 10.2174/1573406412666151112125622 PMID: 26558373
  27. Hanbashi, A. Anti-proliferative mechanism of selective serotonin re-uptake inhibitor sertraline on human metastatic breast cancer cell line MCF7. Doctoral dissertation, Long Island University, The Brooklyn Center, 2014.
  28. Budajaja, F. Anti-proliferative mechanism of selective serotonin reuptakeinhibitor– sertraline-on human metastatic breast cancer cell line, MDA-MB-231. Doctoral dissertation, Long Island University, The Brooklyn Center, 2014.
  29. Sunilkumar, D.; Drishya, G.; Chandrasekharan, A.; Shaji, S.K.; Bose, C.; Jossart, J.; Perry, J.J.P.; Mishra, N.; Kumar, G.B.; Nair, B.G. Oxyresveratrol drives caspase-independent apoptosis-like cell death in MDA-MB-231 breast cancer cells through the induction of ROS. Biochem. Pharmacol., 2020, 173, 113724. doi: 10.1016/j.bcp.2019.113724 PMID: 31756327
  30. Wen, Y.; Zhang, Y.; Li, J.; Luo, F.; Huang, Z.; Liu, K. Low concentration trifluoperazine promotes proliferation and reduces calcium-dependent apoptosis in glioma cells. Sci. Rep., 2018, 8(1), 1147. doi: 10.1038/s41598-018-19413-y PMID: 29348654
  31. Hayashi, K.; Michiue, H.; Yamada, H.; Takata, K.; Nakayama, H.; Wei, F.Y.; Fujimura, A.; Tazawa, H.; Asai, A.; Ogo, N.; Miyachi, H.; Nishiki, T.; Tomizawa, K.; Takei, K.; Matsui, H. Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization. Sci. Rep., 2016, 6(1), 23372. doi: 10.1038/srep23372 PMID: 26988603
  32. Stapel, B.; Melzer, C.; von der Ohe, J.; Hillemanns, P.; Bleich, S.; Kahl, K.G.; Hass, R. Effect of SSRI exposure on the proliferation rate and glucose uptake in breast and ovary cancer cell lines. Sci. Rep., 2021, 11(1), 1250. doi: 10.1038/s41598-020-80850-9 PMID: 33441923
  33. Duarte, D.; Cardoso, A.; Vale, N. Synergistic growth inhibition of HT-29 colon and MCF-7 breast cancer cells with simultaneous and sequential combinations of antineoplastics and CNS Drugs. Int. J. Mol. Sci., 2021, 22(14), 7408. doi: 10.3390/ijms22147408 PMID: 34299028
  34. Duarte, D.; Nunes, M.; Ricardo, S.; Vale, N. Combination of antimalarial and CNS drugs with antineoplastic agents in MCF-7 breast and HT-29 colon cancer cells: Biosafety evaluation and mechanism of action. Biomolecules, 2022, 12(10), 1490. doi: 10.3390/biom12101490 PMID: 36291699
  35. Chen, S.; Xuan, J.; Wan, L.; Lin, H.; Couch, L.; Mei, N.; Dobrovolsky, V.N.; Guo, L. Sertraline, an antidepressant, induces apoptosis in hepatic cells through the mitogen-activated protein kinase pathway. Toxicol. Sci., 2014, 137(2), 404-415. doi: 10.1093/toxsci/kft254 PMID: 24194395
  36. Hodge, J.M.; Wang, Y.; Berk, M.; Collier, F.M.; Fernandes, T.J.; Constable, M.J.; Pasco, J.A.; Dodd, S.; Nicholson, G.C.; Kennedy, R.L.; Williams, L.J. Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function. Biol. Psychiatry, 2013, 74(1), 32-39. doi: 10.1016/j.biopsych.2012.11.003 PMID: 23260229
  37. Atli, O.; Baysal, M.; Aydogan-Kilic, G.; Kilic, V.; Ucarcan, S.; Karaduman, B.; Ilgin, S. Sertraline-induced reproductive toxicity in male rats: Evaluation of possible underlying mechanisms. Asian J. Androl., 2017, 19(6), 672-679. doi: 10.4103/1008-682X.192637 PMID: 27976631
  38. Erdemir, F.; Atilgan, D.; Firat, F.; Markoc, F.; Parlaktas, B.S.; Sogut, E. The effect of Sertraline, Paroxetine, Fluoxetine and Escitalopram on testicular tissue and oxidative stress parameters in rats. Int. Braz J Urol, 2014, 40(1), 100-108. doi: 10.1590/S1677-5538.IBJU.2014.01.15 PMID: 24642156
  39. Tanrikut, C.; Feldman, AS.; Altemus, M.; Paduch, DA.; Schlegel, PN. Adverse effect of paroxetine on sperm. Fertil. Steril., 2010, 94(3), 1021-1026. doi: 10.1016/j.fertnstert.2009.04.039
  40. Gil-Ad, I.; Zolokov, A.; Lomnitski, L.; Taler, M.; Bar, M.; Luria, D.; Ram, E.; Weizman, A. Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice. Int. J. Oncol., 2008, 33(2), 277-286. PMID: 18636148
  41. Xia, D.; Zhang, Y.T.; Xu, G.P.; Yan, W.W.; Pan, X.R.; Tong, J.H. Sertraline exerts its antitumor functions through both apoptosis and autophagy pathways in acute myeloid leukemia cells. Leuk. Lymphoma, 2017, 58(9), 2208-2217. doi: 10.1080/10428194.2017.1287358 PMID: 28278721
  42. Geeraerts, S.L.; Kampen, K.R.; Rinaldi, G.; Gupta, P.; Planque, M.; Louros, N.; Heylen, E.; De Cremer, K.; De Brucker, K.; Vereecke, S.; Verbelen, B.; Vermeersch, P.; Schymkowitz, J.; Rousseau, F.; Cassiman, D.; Fendt, S.M.; Voet, A.; Cammue, B.P.A.; Thevissen, K.; De Keersmaecker, K. Repurposing the antidepressant sertraline as SHMT inhibitor to suppress serine/glycine synthesis–addicted breast tumor growth. Mol. Cancer Ther., 2021, 20(1), 50-63. doi: 10.1158/1535-7163.MCT-20-0480 PMID: 33203732
  43. Krishnan, A.; Hariharan, R.; Nair, S.A.; Pillai, M.R. Fluoxetine mediates G0/G1 arrest by inducing functional inhibition of cyclin dependent kinase subunit (CKS)1. Biochem. Pharmacol., 2008, 75(10), 1924-1934. doi: 10.1016/j.bcp.2008.02.013 PMID: 18371935
  44. Li, Y.; Couch, L.; Higuchi, M.; Fang, J.L.; Guo, L. Mitochondrial dysfunction induced by sertraline, an antidepressant agent. Toxicol. Sci., 2012, 127(2), 582-591. doi: 10.1093/toxsci/kfs100 PMID: 22387747
  45. Then, C.K.; Liu, K.H.; Liao, M.H.; Chung, K.H.; Wang, J.Y.; Shen, S.C. Antidepressants, sertraline and paroxetine, increase calcium influx and induce mitochondrial damage-mediated apoptosis of astrocytes. Oncotarget, 2017, 8(70), 115490-115502. doi: 10.18632/oncotarget.23302 PMID: 29383176
  46. Achenbach, T.V.; Müller, R.; Slater, E.P. Bcl-2 independence of flavopiridol-induced apoptosis. Mitochondrial depolarization in the absence of cytochrome c release. J. Biol. Chem., 2000, 275(41), 32089-32097. doi: 10.1074/jbc.M005267200 PMID: 10896673
  47. Duarte, D.; Guerreiro, I.; Vale, N. Novel strategies for cancer combat: Drug combination using repurposed drugs induces synergistic growth inhibition of MCF-7 breast and HT-29 colon cancer cells. Curr. Issues Mol. Biol., 2022, 44(10), 4930-4949. doi: 10.3390/cimb44100335 PMID: 36286050
  48. Baldissera, A.B.; Boia-Ferreira, M.; Basílio, A.B.C.; Resende, J.S.S.; Castro, M.A.A.; Chaim, O.M.; Gremski, L.H.; Veiga, S.S.; Senff-Ribeiro, A. Sertraline as a potential cancer therapeutic approach: Biological relevance of TCTP in breast cancer cell lines and tumors. Adv. Med. Sci., 2023, 68(2), 227-237. doi: 10.1016/j.advms.2023.06.001 PMID: 37379765

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers